Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VAXX | Class A common stock | Conversion of derivative security | +13.8K | 13.8K | Nov 15, 2021 | Direct | F1, F2 | |||
transaction | VAXX | Class A common stock | Conversion of derivative security | +13.8K | 13.8K | Nov 15, 2021 | Held by spouse | F2, F3, F4 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VAXX | Series A preferred stock | Conversion of derivative security | -21.5K | -100% | 0 | Nov 15, 2021 | Class A common stock | 13.8K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | The Reporting Person unintentionally omitted this transaction from the Form 4 filed on November 15, 2021. |
F2 | Shares of preferred stock automatically converted into shares of Class A common stock upon closing of the Issuer's initial public offering based on a conversion rate of approximately 0.643 shares of Class A common stock for each share of preferred stock. |
F3 | The Reporting Person incorrectly reported that 271,655 shares of Class A common stock were acquired by the Reporting Person's spouse upon the conversion of Series A preferred stock. Instead, 13,824 shares of Class A common stock were acquired by the Reporting Person's spouse upon the conversion of Series A preferred stock. |
F4 | These securities are held by Kristin Diamandis, the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by Kristin Diamandis in which the Reporting Person has no pecuniary interest. |